{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:42:07Z","timestamp":1790692927773,"version":"4.1.0"},"reference-count":51,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T00:00:00Z","timestamp":1428969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Marine Drugs"],"abstract":"<jats:p>This study was designed to investigate the antimicrobial activity of two synthetic antimicrobial peptides from an aquatic organism, tilapia piscidin 3 (TP3) and tilapia piscidin 4 (TP4), in vitro and in a murine sepsis model, as compared with ampicillin, tigecycline, and imipenem. Mice were infected with (NDM-1)-producing  K. pneumonia and multi-drug resistant Acinetobacter baumannii, and subsequently treated with TP3, TP4, or antibiotics for different periods of time (up to 168 h). Mouse survival and bacterial colony forming units (CFU) in various organs were measured after each treatment. Toxicity was determined based on observation of behavior and measurement of biochemical parameters. TP3 and TP4 exhibited strong activity against K. pneumonia and A. baumannii in vitro. Administration of TP3 (150 \u03bcg\/mouse) or TP4 (50 \u03bcg\/mouse)  30 min after infection with K. pneumonia or A. baumannii significantly increased survival in mice. TP4 was more effective than tigecycline at reducing CFU counts in several organs. TP3 and TP4 were shown to be non-toxic, and did not affect mouse behavior. TP3 and TP4 are able at potentiate anti-Acinetobacter baumannii or anti-Klebsiella pneumonia drug activity, reduce bacterial load, and prevent drug resistance, indicating their potential for use in combating multidrug-resistant bacteria.<\/jats:p>","DOI":"10.3390\/md13042287","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T10:32:00Z","timestamp":1429007520000},"page":"2287-2305","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Piscidin is Highly Active against Carbapenem-Resistant Acinetobacter baumannii and NDM-1-Producing Klebsiella pneumonia in a Systemic Septicaemia Infection Mouse Model"],"prefix":"10.3390","volume":"13","author":[{"given":"Chieh-Yu","family":"Pan","sequence":"first","affiliation":[{"name":"Department and Graduate Institute of Aquaculture, National Kaohsiung Marine University, Kaohsiung, Taiwan 811, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Chyi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, Southern Taiwan University, 1 Nan-Tai Street, Yung-Kang City, Tainan County 710, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Te-Li","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Medicine, National Yang-Ming University, No.155, Sec.2, Linong Street,  Taipei 112, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen-Leih","family":"Wu","sequence":"additional","affiliation":[{"name":"Institute of Cellular and Organismic Biology, Academia Sinica, Taipei 112, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cho-Fat","family":"Hui","sequence":"additional","affiliation":[{"name":"Institute of Cellular and Organismic Biology, Academia Sinica, Taipei 112, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyh-Yih","family":"Chen","sequence":"additional","affiliation":[{"name":"Marine Research Station, Institute of Cellular and Organismic Biology, Academia Sinica,  23-10 Dahuen Road, Jiaushi, Ilan 262, Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2015,4,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1093\/jac\/dkq520","article-title":"Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria?","volume":"66","author":"Nordmann","year":"2011","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1179\/joc.2011.23.5.263","article-title":"New Delhi metallo-\u03b2-lactamase (NDM-1): An update","volume":"23","author":"Shakil","year":"2011","journal-title":"J. Chemother."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5046","DOI":"10.1128\/AAC.00774-09","article-title":"Characterization of a new metallo-beta-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India","volume":"53","author":"Yong","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1128\/AAC.01197-13","article-title":"The first NDM metallo-\u03b2-lactamase-producing Enterobacteriaceae isolate in Poland: Evolution of IncFII-type plasmids carrying the blaNDM-1 gene","volume":"58","author":"Fiett","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3201\/eid1101.040001","article-title":"Multidrug-resistant Acinetobacter baumannii","volume":"11","author":"Abbo","year":"2005","journal-title":"Emerg. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"649","DOI":"10.2217\/17460913.3.6.649","article-title":"Drug treatment for multidrug-resistant Acinetobacter baumannii infections","volume":"3","author":"Bassetti","year":"2008","journal-title":"Future Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1128\/JCM.01284-07","article-title":"Antimicrobial resistance among Gram-negative Bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004","volume":"45","author":"Lockhart","year":"2007","journal-title":"J. Clin. Microbiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/02713680590968637","article-title":"A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs","volume":"30","author":"Gordon","year":"2005","journal-title":"Curr. Eye Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"327","DOI":"10.2108\/zsj.29.327","article-title":"Piscidin-1, an antimicrobial peptide from fish (hybrid striped bass Morone saxatilis \u00d7 M. chrysops), induces apoptotic and necrotic activity in HT1080 cells","volume":"29","author":"Lin","year":"2012","journal-title":"Zool. Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1016\/j.biomaterials.2011.01.061","article-title":"Modulation of immune responses by the antimicrobial peptide, epinecidin (Epi)-1, and establishment of an Epi-1-based inactivated vaccine","volume":"32","author":"Huang","year":"2011","journal-title":"Biomaterials"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.peptides.2010.11.005","article-title":"Applications of antimicrobial peptides from fish and perspectives for the future","volume":"32","author":"Rajanbabu","year":"2011","journal-title":"Peptides"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/35104690","article-title":"Peptide antibiotics in mast cells of fish","volume":"414","author":"Silphaduang","year":"2001","journal-title":"Nature"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.fsi.2013.05.007","article-title":"Characterization of a novel piscidin-like antimicrobial peptide from Pseudosciaena crocea and its immune response to Cryptocaryon irritans","volume":"35","author":"Niu","year":"2013","journal-title":"Fish Shellf. Immunol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/nbt.2572","article-title":"Antimicrobial peptides stage a comeback","volume":"31","author":"Fox","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.peptides.2008.10.007","article-title":"Epinecidin-1, an antimicrobial peptide from fish (Epinephelus coioides) which has an antitumor effect like lytic peptides in human fibrosarcoma cells","volume":"30","author":"Lin","year":"2009","journal-title":"Peptides"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.1128\/AAC.00064-12","article-title":"Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide","volume":"56","author":"Korolik","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e50263","DOI":"10.1371\/journal.pone.0050263","article-title":"Five different piscidins from Nile Tilapia, Oreochromis niloticus: Analysis of their expressions and biological functions","volume":"7","author":"Peng","year":"2012","journal-title":"PLoS ONE"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.dci.2008.05.015","article-title":"The antimicrobial peptides piscidins are stored in the granules of professional phagocytic granulocytes of fish and are delivered to the bacteria-containing phagosome upon phagocytosis","volume":"32","author":"Mulero","year":"2008","journal-title":"Dev. Comp. Immunol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3354\/dao072241","article-title":"Evidence for widespread distribution of piscidin antimicrobial peptides in teleost fish","volume":"72","author":"Silphaduang","year":"2006","journal-title":"Dis. Aquat. Organ."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.burns.2012.02.025","article-title":"Phenotypic detection of Klebsiella pneumoniae carbapenemase among burns patients: First report from Iran","volume":"39","author":"Azimi","year":"2013","journal-title":"Burns"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1128\/AAC.01232-12","article-title":"Randomized phase 2 trial to evaluate the clinical efficacy of two high-dosage tigecycline regimens versus imipenem-cilastatin for treatment of hospital-acquired pneumonia","volume":"57","author":"Ramirez","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_22","first-page":"541","article-title":"Imipenem-induced Clostridium difficile diarrhea in a patient with chronic renal failure","volume":"22","author":"Enriquez","year":"2011","journal-title":"Saudi. J. Kidney Dis. Transpl."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1128\/AAC.05682-11","article-title":"Bactericidal activity of multiple combinations of tigecycline and colistin against NDM-1-producing Enterobacteriaceae","volume":"56","author":"Albur","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S1473-3099(10)70143-2","article-title":"Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: A molecular, biological, and epidemiological study","volume":"10","author":"Kumarasamy","year":"2010","journal-title":"Lancet Infect. Dis."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1128\/JCM.00404-09","article-title":"Pharmacokinetic considerations regarding tigecycline for multidrug-resistant (MDR) Klebsiella pneumoniae or MDR Acinetobacter baumannii urosepsis","volume":"47","author":"Cunha","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3855\/jidc.2604","article-title":"Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009\u20132011","volume":"7","author":"Haeili","year":"2013","journal-title":"J. Infect. Dev. Ctries"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.mib.2004.08.013","article-title":"Taking inventory: Antibacterial agents currently at or beyond phase 1","volume":"7","author":"Bush","year":"2004","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1021\/jm050347i","article-title":"Designer antibacterial peptides kill fluoroquinolone-resistant clinical isolates","volume":"48","author":"Otvos","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1093\/jac\/dkq337","article-title":"Preclinical advantages of intramuscularly administered peptide A3-APO over existing therapies in Acinetobacter baumannii wound infections","volume":"65","author":"Ostorhazi","year":"2010","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1016\/j.biomaterials.2013.11.035","article-title":"Anti-mycobacterial activities of synthetic cationic \u03b1-helical peptides and their synergism with rifampicin","volume":"35","author":"Khara","year":"2014","journal-title":"Biomaterials"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1128\/AAC.47.10.3349-3351.2003","article-title":"Activity of human beta-defensin 3 alone or combined with other antimicrobial agents against oral bacteria","volume":"47","author":"Maisetta","year":"2003","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1128\/AAC.50.2.806-809.2006","article-title":"In vitro bactericidal activity of human beta-defensin 3 against multidrug-resistant nosocomial strains","volume":"50","author":"Maisetta","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"52820","DOI":"10.1074\/jbc.C400485200","article-title":"alpha2-Macroglobulin-proteinase complexes protect Streptococcus pyogenes from killing by the antimicrobial peptide LL-37","volume":"279","author":"Nyberg","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1128\/AAC.49.4.1432-1440.2005","article-title":"Acquisition of resistance to carbapenems in multidrug-resistant clinical strains of Acinetobacter baumannii: Natural insertional inactivation of a gene encoding a member of a novel family of beta-barrel outer membrane proteins","volume":"49","author":"Mussi","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.peptides.2013.09.014","article-title":"Antimicrobial activity of nisin against the swine pathogen Streptococcus suis and its synergistic interaction with antibiotics","volume":"50","author":"Lebel","year":"2013","journal-title":"Peptides"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s100960100609","article-title":"Ceftazidime- and imipenem-induced endotoxin release during treatment of gram-negative infections","volume":"20","author":"Byl","year":"2001","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"30577","DOI":"10.1074\/jbc.M110.137935","article-title":"Tilapia hepcidin 2\u20133 peptide modulates lipopolysaccharide-induced cytokines and inhibits tumor necrosis factor-alpha through cyclooxygenase-2 and phosphodiesterase 4D","volume":"285","author":"Rajanbabu","year":"2010","journal-title":"J. Biol. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1096\/fj.09-145474","article-title":"A novel tetrabranched antimicrobial peptide that neutralizes bacterial lipopolysaccharide and prevents septic shock in vivo","volume":"24","author":"Pini","year":"2010","journal-title":"FASEB J."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/gut.52.6.874","article-title":"Administration of protegrin peptide IB-367 to prevent endotoxin induced mortality in bile duct ligated rats","volume":"52","author":"Giacometti","year":"2003","journal-title":"Gut"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1128\/AAC.48.8.3127-3129.2004","article-title":"In vitro activity and potency of an intravenously injected antimicrobial peptide and its dl amino acid analog in mice infected with bacteria","volume":"48","author":"Braunstein","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1128\/AAC.06304-11","article-title":"Efficacy of OH-CATH30 and its analogs against drug-resistant bacteria in vitro and in mouse models","volume":"56","author":"Li","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1128\/AAC.01678-08","article-title":"In vivo pharmacodynamic profile of tigecycline against phenotypically diverse Escherichia coli and Klebsiella pneumoniae isolates","volume":"53","author":"Nicasio","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clinthera.2005.01.007","article-title":"Tigecycline: An investigational glycylcycline antimicrobial with activity against resistant gram-positive organisms","volume":"27","author":"Garrison","year":"2005","journal-title":"Clin. Ther."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.diagmicrobio.2007.10.017","article-title":"Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centers","volume":"60","author":"Gales","year":"2008","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S1726-4901(10)70129-5","article-title":"First identification of a patient colonized with Klebsiella pneumoniae carrying blaNDM-1 in Taiwan","volume":"73","author":"Wu","year":"2010","journal-title":"J. Chin. Med. Assoc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.jmii.2012.08.006","article-title":"Dissemination of multidrug-resistant Acinetobacter baumannii carrying BlaOxA-23 from hospitals in central Taiwan","volume":"46","author":"Lee","year":"2013","journal-title":"J. Microbiol. Immunol. Infect."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1016\/j.peptides.2009.02.006","article-title":"In vitro activities of three synthetic peptides derived from epinecidin-1 and an anti-lipopolysaccharide factor against Propionibacterium acnes, Candida albicans, and Trichomonas vaginalis","volume":"30","author":"Pan","year":"2009","journal-title":"Peptides"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1016\/j.peptides.2010.05.011","article-title":"Evaluation of the epinecidin-1 peptide as an active ingredient in cleaning solutions against pathogens","volume":"31","author":"Pan","year":"2010","journal-title":"Peptides"},{"key":"ref_49","unstructured":"National Committee for Clinical Laboratory Standards (2003). Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. M7-A6, National Committee for Clinical Laboratory Standards. [6th ed.]."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"8841","DOI":"10.1016\/j.biomaterials.2012.08.026","article-title":"Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection","volume":"33","author":"Huang","year":"2012","journal-title":"Biomaterials"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1016\/S0142-9612(02)00036-4","article-title":"Interactions between dendrimer biocides and bacterial membranes","volume":"23","author":"Chen","year":"2002","journal-title":"Biomaterials"}],"container-title":["Marine Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-3397\/13\/4\/2287\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T20:44:40Z","timestamp":1760215480000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-3397\/13\/4\/2287"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,14]]},"references-count":51,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4]]}},"alternative-id":["md13042287"],"URL":"https:\/\/doi.org\/10.3390\/md13042287","relation":{},"ISSN":["1660-3397"],"issn-type":[{"value":"1660-3397","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,14]]}}}